Probes Underway In Novartis Turkey Bribery Allegations
This article was originally published in PharmAsia News
Executive Summary
An anonymous whistleblower has accused Swiss pharmaceutical giant Novartis of benefiting from business advantages allegedly brokered by a local consulting firm, in claims that have shaken the Turkish pharma industry but have been dismissed as “untrue accusations” by the company, which is probing the affair.